In addition, inhibitors of the canonical Wnt pathway such as sclerostin, DKK1, and secreted Frizzled-related protein (sFRP)2/3 are elevated in MM and inhibit bone formation by preventing β-catenin signaling [63,82,83]. The gene discussed is SOST; the disease is Miyoshi myopathy.